First Look: CRF Health’s ‘Outstanding Innovation’ with Pioneering TrialConsent Wins Industry Recognition

On Thursday, MHW learned that CRF Health — a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry — has just confirmed that its electronic informed consent solution, TrialConsent, has won the 2018 Best Practices Award at this year’s Clinical Informatics News Awards.

The Best Practices Awards program seeks to recognize outstanding examples of applied strategic innovation—partnerships, deployments and collaborations that manifestly improve the clinical trial process.

The judges named nine finalists, and from that pool chose winning entries in three categories: Clinical Data Intelligence; Study Startup and Design; and Patient Data Management. CRF Health were winners of the Study Startup and Design Award. The Awards were announced at SCOPE, the Summit for Clinical Ops Executives in Orlando, Florida, on February 14.

We’re told that this is the second award in 2018 recognizing CRF Health as a disruptive force for innovative, high value-driven health tech solutions.

CRF Health’s TrialConsent is an industry-first hybrid electronic informed consent solution fully integrated within an eCOA platform.

Commenting on the award recognition in a provided media release, CRF Health’s CEO, Rachael Wyllie said: “Electronic methods of informed consent reduce some of the most cited regulatory deficiencies. With TrialConsent, we’ve worked alongside sponsors, sites and IRBs to understand their needs and to develop an intuitive eConsent platform that is robust and reliable, yet incredibly easy-to-use, and we are delighted that our solution has been selected as a winner in the 2018 Clinical informatic News Awards.” Wyllie added: “As an industry-first hybrid solution, TrialConsent makes the informed consent process more effective and more efficiently streamlined for all stakeholders. By allowing trial designs to easily integrate electronic informed consent and eCOA solutions on a single platform and even on the same device, TrialConsent removes the need for a separate consenting technology, significantly reducing complexity for researchers.”

For further information on CRF Health and the TrialConsent solution, click here.

This post was written by:

- who has written 371 posts on mHealthWatch.

Contact the author